Filana Therapeutics (FLNA) Cash from Investing Activities (2010 - 2025)
Filana Therapeutics (FLNA) posted quarterly Cash from Investing Activities of -$501000.0 for Q4 2025, down 778.95% year-over-year from $73790.7 in Q4 2024, and down 526.25% quarter-over-quarter from -$80000.0 in Q3 2025.
Filana Therapeutics (FLNA) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Filana Therapeutics' Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$501000.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 778.95% year-over-year to -$501000.0; the TTM figure through Dec 2025 stood at -$581000.0 (down 464.08% YoY), while the FY2025 annual figure was -$581000.0, down 464.08% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$501000.0, down from -$80000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $335000.0 in Q4 2022, with the low at -$22.0 million in Q3 2021.
- The 5-year median for Cash from Investing Activities is -$80000.0 (2025), against an average of -$1.7 million.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities surged 435.0% in 2022, then plunged 778.95% in 2025.
- Filana Therapeutics' Cash from Investing Activities stood at -$100000.0 in 2021, then soared by 435.0% to $335000.0 in 2022, then tumbled by 112.24% to -$41000.0 in 2023, then plunged by 39.02% to -$57000.0 in 2024, then slumped by 778.95% to -$501000.0 in 2025.
- Business Quant data shows FLNA's Cash from Investing Activities at -$501000.0 in Q4 2025, -$80000.0 in Q3 2025, and -$57000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -501,000.00 |
| Dec 31, 2025 | -501,000.00 |
| Sep 30, 2025 | -80,000.00 |
| Sep 30, 2025 | -80,000.00 |
| Dec 31, 2024 | -57,000.00 |
| Dec 31, 2024 | -57,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | -22,000.00 |
| Sep 30, 2023 | -22,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | -357,000.00 |
| Mar 31, 2023 | -357,000.00 |
| Dec 31, 2022 | 335,000.00 |
| Dec 31, 2022 | 335,000.00 |